EDT — Spectral Medical Share Price
0.000.00%
Last trade - 00:00- CA$233.80m
- CA$245.73m
- CA$2.29m
- 38
- 12
- 92
- 45
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 102.27 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | -673.45% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CA$m | 2.1 | 2.05 | 1.67 | 1.6 | 2.29 | 2.4 | 86.6 | -4.43% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.
Directors
- Anthony Bihl NEC (65)
- Paul Walker PRE
- Chris Seto CEO
- Gualitiero Guadagni VPR
- Debra Foster VPR
- John Kellum OTH
- Jan Dalvise IND
- Jun Hayakawa IND
- John Nosenzo IND (63)
- William Stevens IND
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- April 1st, 2005
- Public Since
- July 16th, 1992
- No. of Employees
- 29
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Toronto Stock Exchange
- Shares in Issue
- 285,117,225
- Address
- 135 The West Mall, Unit 2, TORONTO, M9C 1C2
- Web
- https://spectraldx.com/
- Phone
- +1 4166263233
- Contact
- Ali Mahdavi
- Auditors
- PricewaterhouseCoopers LLP
Upcoming Events for EDT
Q1 2025 Spectral Medical Inc Earnings Release
Spectral Medical Inc Annual Shareholders Meeting
Spectral Medical Inc Annual Shareholders Meeting
Q2 2025 Spectral Medical Inc Earnings Release
Similar to EDT
Aptose Biosciences
Toronto Stock Exchange
Aurora Cannabis
Toronto Stock Exchange
Auxly Cannabis
Toronto Stock Exchange
Bausch Health Companies
Toronto Stock Exchange
Canopy Growth
Toronto Stock Exchange
FAQ
What is the Spectral Medical share price?
As of Today at 23:22 UTC, shares in Spectral Medical are trading at CA$0.82. This share price information is delayed by 15 minutes.
How has the Spectral Medical share price performed this year?
Shares in Spectral Medical last closed at CA$0.82 and the price had moved by +86.36% over the past 365 days. In terms of relative price strength the Spectral Medical share price has outperformed the Toronto Stock Exchange 300 Composite Index by +67.99% over the past year.
What are the analyst and broker recommendations for Spectral Medical?
The overall consensus recommendation for Spectral Medical is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Spectral Medical dividend yield?
Spectral Medical does not currently pay a dividend.
Does Spectral Medical pay a dividend?
Spectral Medical does not currently pay a dividend.
When does Spectral Medical next pay dividends?
Spectral Medical does not currently pay a dividend.
How do I buy Spectral Medical shares?
To buy shares in Spectral Medical you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Spectral Medical?
As of the previous close price of CA$0.82, shares in Spectral Medical had a market capitalisation of CA$233.80m.
Where are Spectral Medical shares listed?
Here are the trading details for Spectral Medical:
- Country of listing: Canada
- Exchange: TOR
- Ticker Symbol: EDT
What kind of share is Spectral Medical?
Based on an overall assessment of its quality, value and momentum Spectral Medical is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Spectral Medical share price forecast for 2025?
The analyst consensus target price for shares in Spectral Medical is CA$2.00. That is 143.9% above the last closing price of CA$0.82.
Analysts covering Spectral Medical currently have a consensus Earnings Per Share (EPS) forecast of -CA$0.03 for the next financial year.
Find out moreWhat is the trend in the Spectral Medical share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Spectral Medical. Over the past six months, its share price has outperformed the Toronto Stock Exchange 300 Composite Index by +37.37%.
As of the last closing price of CA$0.82, shares in Spectral Medical were trading +36.68% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Spectral Medical PE Ratio?
The Spectral Medical PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$0.82.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Spectral Medical?
Spectral Medical's management team is headed by:
- Anthony Bihl - NEC
- Paul Walker - PRE
- Chris Seto - CEO
- Gualitiero Guadagni - VPR
- Debra Foster - VPR
- John Kellum - OTH
- Jan Dalvise - IND
- Jun Hayakawa - IND
- John Nosenzo - IND
- William Stevens - IND